Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter and Prospective Phase II Trial With Gemcitabine and Rapamycin in Second Line of Metastatic Osteosarcoma

NCT02429973 is registered in ClinicalTrials.gov with Broto, Javier Martín, M.D. as lead sponsor.

NCT NCT02429973
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02429973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter and Prospective Phase II Trial With Gemcitabine and Rapamycin in Second Line of Metastatic Osteosarcoma
Lead sponsor
Broto, Javier Martín, M.D.
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2012
Completion date
April 30, 2015
Enrollment
33 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

osteosarcoma